3 Recruiting Neuroendocrine Tumors Clinical Trials in California
Explore active neuroendocrine tumors research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Neuroendocrine Tumors Studies in California
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Interventional Protocol 📊 Observational Clinical Research
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔